[Counterfeit drugs as a gobal threat to health]
- PMID: 21789919
- DOI: 10.2298/mpns1106285g
[Counterfeit drugs as a gobal threat to health]
Abstract
According to the World Health Organisation, counterfeit medicines are medicines that are mislabelled deliberately and fraudulently regarding their identity and/or source. All kinds of medicines have been counterfeited, both branded and generic ones. Counterfeit medicines may include products containing correct or wrong ingredients; without active or with insufficiently or over-active ingredients, or with fake packaging. Many sources of information have been explored, including reports from the national medicine regulatory authorities, pharmaceutical companies and literature data. Since the time counterfeit drugs first appeared, they have become more sophisticated and more difficult to be detected. The World Health Organisation estimate is that up to 1% of medicines available in the developed world are likely to be counterfeit. This figure rises to 10% globally, although in some developing countries it is 50%. The World Health Organisation estimate is that 50% of medicines available via the internet are counterfeit. The knowledge about counterfeit drugs should be used to educate students of pharmacy and medicine, health professionals and patients. The most important players in campaign against counterfeit medicines are health professionals. Pharmacists and doctors should stay vigilant and report suspicious products, and consider counterfeits as a possible cause of adverse reactions or therapeutic failure. Patients should inform their pharmacists and doctors if they suspect any irregularity concerning their medication, if they experience side effects or a decrease in beneficial effect. The crucial step in the prevention of counterfeit medicines is to get supplied from reliable sources, i.e. licensed pharmacies.
Similar articles
-
[Counterfeit medicines: a growing threat].Med Trop (Mars). 2006 Dec;66(6):529-32. Med Trop (Mars). 2006. PMID: 17286014 French.
-
[Counterfeit medicines--Japan and the world].Yakugaku Zasshi. 2014;134(2):213-22. doi: 10.1248/yakushi.13-00230-3. Yakugaku Zasshi. 2014. PMID: 24492225 Review. Japanese.
-
[Anti-counterfeit activities of pharmaceutical companies in Japan: for patient safety].Yakugaku Zasshi. 2014;134(2):203-11. doi: 10.1248/yakushi.13-00230-2. Yakugaku Zasshi. 2014. PMID: 24492224 Review. Japanese.
-
Perceptions and practices of pharmaceutical wholesalers surrounding counterfeit medicines in a developing country: a baseline survey.BMC Health Serv Res. 2011 Nov 11;11:306. doi: 10.1186/1472-6963-11-306. BMC Health Serv Res. 2011. PMID: 22074046 Free PMC article.
-
Problems associated with substandard and counterfeit drugs in developing countries: a review article on global implications of counterfeit drugs in the era of antiretroviral (ARVs) drugs in a free market economy.East Afr J Public Health. 2008 Dec;5(3):205-10. doi: 10.4314/eajph.v5i3.39004. East Afr J Public Health. 2008. PMID: 19374325 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical